243 | REAL‐WORLD OUTCOMES OF CD20xCD3 BISPECIFIC ANTIBODY THERAPY IN ADULT PATIENTS WITH RELAPSED/REFRACTORY TRANSFORMED INDOLENT LYMPHOMAP. Stéphan, Alexey V. Danilov, Amrita Chauhan et al.|Hematological Oncology|2025Cited by 1
667 | REAL‐WORLD SAFETY AND EFFICACY OF EPCORITAMAB FOR PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMASAllison M. Bock, Saira Ahmed, Lei Feng et al.|Hematological Oncology|2025Cited by 0
161 | OUTCOMES OF GLOFITAMAB AND EPCORITAMAB IN R/R DLBCL ELDERLY PATIENTS: A REAL‐WORLD EVIDENCE STUDY FROM THE CUBIC CONSORTIUMAmrita Chauhan, Liangyi Chen, Sairah Ahmed et al.|Hematological Oncology|2025Cited by 0